Search Media Items

Information about the NCI grants process, including recipient eligibility, the different people involved, and information about funding.

Contact a grants management specialist assigned to your institution.

Requirements and reports to comply with grant closeout, including Final Federal Financial Report (FFR, SF425); Final Research Performance Progress Report (FRPPR); Interim Research Performance Progress Report (IRPPR); Final Invention Statement (FIS, HHS

Basic information about cancer disparities in the U.S., factors that contribute to the disproportionate burden of cancer in some groups, and examples of disparities in incidence and mortality among certain populations.

Access NCI-supported cancer clinical trials information through an application programming interface (API).

Resumen de información revisada por expertos acerca de las características genómicas de los cánceres infantiles. En este sumario se describen los subtipos moleculares de tipos específicos de cáncer infantil y las características clínicas relacionadas, las alteraciones genómicas recurrentes que caracterizan cada subtipo en el momento del diagnóstico o recidiva, y la importancia terapéutica y pronóstica de estas alteraciones. Se tratan las alteraciones genómicas relacionadas con tumores de encéfalo, tumores de riñón, leucemias, linfomas y otros tipos de cáncer.

A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.

A review of current research identifying and testing drug combination approaches that have the potential to overcome or delay resistance to cancer treatment.

In this study, men diagnosed with androgen-sensitive prostate cancer with intermediate- or high-risk features will be examined with mpMRI, undergo targeted biopsies, and be treated with neoadjuvant androgen deprivation therapy.

La investigación del NCI de prevención va desde identificación de factores ambientales y de estilos de vida que influyen en el riesgo de cáncer hasta la biología de la formación del cáncer y la evaluación para diseminar intervenciones de prevención.